Pharma and OTC Supplements Market to Reach USD 565.76 Billion by 2032 | North America Holds 35.6% Market Share | Key Players: Pfizer Inc., Bayer AG, GSK plc

The global pharma and OTC supplements market was valued at USD 336.76 billion in 2024 and is projected to reach nearly USD 565.76 billion by 2032, growing at a CAGR of 6.70% during the forecast period from 2025 to 2032.